Healthcare+ Expo, Taiwan 2023： Memory T-Cell Immunotherapy Brings New Hope for Cancer Patients

Share：

Lukas Biomedical successfully completed a four-day exhibition at the Healthcare+ Expo, Taiwan 2023, attracting many attendees interested in learning more about immunocellular cancer therapy. Visitors included cancer patients themselves as well as family members and friends seeking information on their behalf. Some attendees brought their medical records for in-depth discussions with professional physicians at the event. After carefully listening to the explanations, many decided to opt for immunocellular cancer therapy. The exhibition was filled with confidence and anticipation for this innovative treatment.

Lukas Biomedical is deeply honored to see so many patients willing to try immune cell therapy for cancer, filled with confidence. In this fight against cancer, patients and medical teams work hand in hand, facing challenges together. The professional medical team at Luka Biomedical is committed to doing everything possible to provide the highest quality and most professional care, hoping that every patient can achieve the greatest health benefits and overcome cancer together.

To deepen the understanding of cancer treatment among visitors, Luka Biomedical hosted two high-quality cancer medical seminars. These seminars were led by Dr. and Professor Chen Guang-Yao, Consultant of the Particle Therapy and Radiation Oncology Department at Taipei Veterans General Hospital; Dr. Xie Ying-Hua, Chief Professor at Chang Gung Memorial Hospital; Dr. Liu Bing-Zhong, Convener and Executive Physician at Banqiao Zhongxing Hospital's Cell Therapy Center; and Dr. Tang Zhi-Chao, Chairman of Luka Biomedical and an expert in immune cell cancer therapy.

These doctors and experts explained that immune cell cancer therapy is a non-toxic, non-invasive green treatment with very low and mild side effects, allowing patients to maintain their quality of life during cancer treatment. Among all immune cell therapies, memory T-cell therapy possesses immunological memory and specificity, with a long survival cycle that can last over a year in the human body. In case of cancer recurrence, these cells can be reactivated to eliminate cancer cells, offering a significant advantage in preventing cancer recurrence. These two high-quality seminars not only provided deeper cancer knowledge but also addressed many questions from the audience, encouraging more people to bravely make decisions regarding cancer treatment.